Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Anastos

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association|January 19, 2018
Cell death under epithelial-mesenchymal transition control in prostate cancer therapeutic responseDiane Begemann, Harry Anastos, Natasha Kyprianou
World Journal of Urology|January 27, 2024
Comment on 'A new position utilizing the effect of gravity in proximal ureteral stones, ureteroscopic lithotripsy in the reverse Trendelenburg position: a prospective, randomized, comparative study'Harry Anastos, Alan J Yaghoubian, Mantu Gupta
Cancer Treatment and Research|September 1, 2018
Targeted Ablative Therapies for Prostate CancerJared S Winoker, Harry Anastos, Ardeshir R Rastinehad
World Journal of Urology|June 4, 2018
Immune phenotype of peripheral blood mononuclear cells in patients with high-risk non-muscle invasive bladder cancerFrançois Audenet, Adam M Farkas, Harry Anastos, et al.
BJUI Compass|February 23, 2023
Factors that influence preference for male or female urologist among underserved patients in New York CityShirin Razdan, Patrick Ho, Christine Bieber, et al.
Urologic Oncology|July 16, 2020
TIM-3 and TIGIT are possible immune checkpoint targets in patients with bladder cancerKyrollis Attalla, Adam M Farkas, Harry Anastos, et al.
Urologic Oncology|June 9, 2019
Clinicopathological and survival analysis of clinically advanced papillary and chromophobe renal cell carcinomaAlain Kaldany, David J Paulucci, Muthumeena Kannappan, et al.
Urologic Oncology|October 17, 2017
Demographic and socioeconomic predictors of treatment delays, pathologic stage, and survival among patients with penile cancer: A report from the National Cancer DatabaseKyrollis Attalla, David J Paulucci, Kyle Blum, et al.
Urologic Oncology|September 20, 2020
Black race may be associated with worse overall survival in renal cell carcinoma patientsHarry Anastos, Alberto Martini, Nikhil Waingankar, et al.
The Journal of Urology|April 13, 2017
Predicting Complications Following Robot-Assisted Partial Nephrectomy with the ACS NSQIP<sup>®</sup> Universal Surgical Risk CalculatorJared S Winoker, David J Paulucci, Harry Anastos, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
International Journal of Urology : Official Journal of the Japanese Urological Association|January 19, 2018
Cell death under epithelial-mesenchymal transition control in prostate cancer therapeutic responseDiane Begemann, Harry Anastos, Natasha Kyprianou
World Journal of Urology|January 27, 2024
Comment on 'A new position utilizing the effect of gravity in proximal ureteral stones, ureteroscopic lithotripsy in the reverse Trendelenburg position: a prospective, randomized, comparative study'Harry Anastos, Alan J Yaghoubian, Mantu Gupta
Cancer Treatment and Research|September 1, 2018
Targeted Ablative Therapies for Prostate CancerJared S Winoker, Harry Anastos, Ardeshir R Rastinehad
World Journal of Urology|June 4, 2018
Immune phenotype of peripheral blood mononuclear cells in patients with high-risk non-muscle invasive bladder cancerFrançois Audenet, Adam M Farkas, Harry Anastos, et al.
BJUI Compass|February 23, 2023
Factors that influence preference for male or female urologist among underserved patients in New York CityShirin Razdan, Patrick Ho, Christine Bieber, et al.
Urologic Oncology|July 16, 2020
TIM-3 and TIGIT are possible immune checkpoint targets in patients with bladder cancerKyrollis Attalla, Adam M Farkas, Harry Anastos, et al.
Urologic Oncology|June 9, 2019
Clinicopathological and survival analysis of clinically advanced papillary and chromophobe renal cell carcinomaAlain Kaldany, David J Paulucci, Muthumeena Kannappan, et al.
Urologic Oncology|October 17, 2017
Demographic and socioeconomic predictors of treatment delays, pathologic stage, and survival among patients with penile cancer: A report from the National Cancer DatabaseKyrollis Attalla, David J Paulucci, Kyle Blum, et al.
Urologic Oncology|September 20, 2020
Black race may be associated with worse overall survival in renal cell carcinoma patientsHarry Anastos, Alberto Martini, Nikhil Waingankar, et al.
The Journal of Urology|April 13, 2017
Predicting Complications Following Robot-Assisted Partial Nephrectomy with the ACS NSQIP<sup>®</sup> Universal Surgical Risk CalculatorJared S Winoker, David J Paulucci, Harry Anastos, et al.
Pageof 2